1. Bulun, SE, Cheng, YH, Pavone, ME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin Reprod Med 2010; 28: 36–43.
Google Scholar | Crossref | Medline2. Ezzat, L. Medical treatment of endometriosis: an update. Int J Reprod Contracept Obstet Gynecol 2017; 6: 4187–4192.
Google Scholar | Crossref3. Culley, L, Law, C, Hudson, N, et al. The social and psychological impact of endometriosis on women’s lives: a critical narrative review. Hum Reprod Update 2013; 19: 625–639.
Google Scholar | Crossref | Medline4. De Graaff, AA, D’Hooghe, TM, Dunselman, GA, et al. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod 2013; 28: 2677–2685.
Google Scholar | Crossref | Medline5. Fourquet, J, Baez, L, Figueroa, M, et al. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril 2011; 96: 107–112.
Google Scholar | Crossref | Medline6. Moradi, M, Parker, M, Sneddon, A, et al. Impact of endometriosis on women’s lives: a qualitative study. BMC Womens Health 2014; 14: 123.
Google Scholar | Crossref | Medline7. Nnoaham, KE, Hummelshoj, L, Webster, P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011; 96: 366–373 e368.
Google Scholar | Crossref | Medline8. Soliman, AM, Surrey, E, Bonafede, M, et al. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther 2018; 35: 408–423.
Google Scholar | Crossref | Medline9. Wills, H, Demetriou, C, May, K, et al. Endometriosis annual evidence update. NHS Evidence – women’s health, 2010.
Google Scholar10. Dunselman, GA, Vermeulen, N, Becker, C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod 2014; 29: 400–412.
Google Scholar | Crossref | Medline11. Eisenberg, VH, Weil, C, Chodick, G, et al. Epidemiology of endometriosis: a large population-based database study from a healthcare provider with 2 million members. BJOG 2018; 125: 55–62.
Google Scholar | Crossref | Medline12. Parasar, P, Ozcan, P, Terry, KL. Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 2017; 6: 34–41.
Google Scholar | Crossref | Medline13. Rolla, E. Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment. F1000Res 2019; 8: 529. DOI:10.12688/f1000research.14817.1.
Google Scholar | Crossref | Medline14. NICE . National Institute for Health and Care Excellence: Clinical Guidelines, https://www.ncbi.nlm.nih.gov/pubmed/29787038 (2017, accessed 17 June 2020).
Google Scholar15. Practice Committee of the American Society for Reproductive Medicine . Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril 2014; 101(4): 927–935.
Google Scholar | Crossref | Medline16. Ferrero, S, Evangelisti, G, Barra, F. Current and emerging treatment options for endometriosis. Expert Opin Pharmacother 2018; 19: 1109–1125.
Google Scholar | Crossref | Medline17. Vercellini, P, Fedele, L, Pietropaolo, G, et al. Progestogens for endometriosis: forward to the past. Hum Reprod Update 2003; 9: 387–396.
Google Scholar | Crossref | Medline18. Casper, RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017; 107: 533–536.
Google Scholar | Crossref | Medline19. Lee, JH, Song, JY, Yi, KW, et al. Effectiveness of dienogest for treatment of recurrent endometriosis: multicenter data. Reprod Sci 2018; 25: 1515–1522.
Google Scholar | SAGE Journals20. Schindler, AE. Dienogest in long-term treatment of endometriosis. Int J Womens Health 2011; 3: 175–184.
Google Scholar | Crossref | Medline21. Strowitzki, T, Faustmann, T, Gerlinger, C, et al. Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. Int J Womens Health 2015; 7: 393–401.
Google Scholar | Crossref | Medline22. Hirsch, M, Begum, MR, Paniz, E, et al. Diagnosis and management of endometriosis: a systematic review of international and national guidelines. BJOG 2018; 125: 556–564.
Google Scholar | Crossref | Medline23. Dinger, J, Do Minh, T, Buttmann, N, et al. Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen. Obstet Gynecol 2011; 117: 33–40.
Google Scholar | Crossref | Medline24. Dinger, J, Do Minh, T, Heinemann, K. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception 2016; 94: 328–339.
Google Scholar | Crossref | Medline25. Dinger, JC, Heinemann, LA, Kuhl-Habich, D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception 2007; 75: 344–354.
Google Scholar | Crossref | Medline26. Heinemann, K, Imthurn, B, Marions, L, et al. Safety of dienogest and other hormonal treatments for endometriosis in real-world clinical practice (VIPOS): a large noninterventional study. Adv Ther 2020; 37: 2528–2537.
Google Scholar | Crossref | Medline27. Moehner, S, Becker, K, Lange, J, et al. Risk of depression and anemia in users of hormonal endometriosis treatments: results from the VIPOS study. Eur J Obstet Gynecol Reprod Biol 2020; 251: 212–217.
Google Scholar | Crossref | Medline28. Leyland, N, Casper, R, Laberge, P, et al. Endometriosis: diagnosis and management. J Obstet Gynaecol Can 2010; 32: S1–S32.
Google Scholar | Crossref | Medline29. Chapron, C, Marcellin, L, Borghese, B, et al. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol 2019; 15: 666–682.
Google Scholar | Crossref | Medline30. Johnson, NP, Hummelshoj, L and World Endometriosis Society Montpellier C. Consensus on current management of endometriosis. Hum Reprod 2013; 28: 1552–1568.
Google Scholar | Crossref | Medline31. Jensen, JT, Schlaff, W, Gordon, K. Use of combined hormonal contraceptives for the treatment of endometriosis-related pain: a systematic review of the evidence. Fertil Steril 2018; 110: 137–152 e131.
Google Scholar | Crossref32. Muzii, L, Di Tucci, C, Achilli, C, et al. Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis. Am J Obstet Gynecol 2016; 214: 203–211.
Google Scholar | Crossref | Medline33. Jee, BC, Lee, JY, Suh, CS, et al. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril 2009; 91: 40–45.
Google Scholar | Crossref | Medline34. Adachi, K, Takahashi, K, Nakamura, K, et al. Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas. Gynecol Endocrinol 2016; 32: 646–649.
Google Scholar | Crossref | Medline35. Ota, Y, Andou, M, Yanai, S, et al. Long-term administration of dienogest reduces recurrence after excision of endometrioma. J Endometr Pelvic Pain Disord 2015; 7: 63–67.
Google Scholar | Abstract36. Yamanaka, A, Hada, T, Matsumoto, T, et al. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis. Eur J Obstet Gynecol Reprod Biol 2017; 216: 51–55.
Google Scholar | Crossref | Medline